Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 3.2 M3.25 M4.36 M4.05 M 14.86 M Research & development ———— — Operating income 15.25 M14.93 M14.97 M20.79 M 65.94 M Non-Operating Income, Total 104 K106 K254 K435 K 899 K Interest expense, net of interest capitalized 7.53 M8.19 M8.64 M9.3 M 33.67 M Non-Operating Income, excl. Interest Expenses -7.43 M-8.08 M-8.39 M-8.87 M -32.77 M Unusual income/expense ———— — Pretax income 5.73 M6.28 M5.64 M9.44 M 27.09 M Equity in earnings -35 K-43 K-49 K-18 K -145 K Taxes 1.22 M1.49 M1.28 M2.03 M 6.02 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 4.47 M4.75 M4.31 M7.4 M 20.93 M Discontinued operations ———— — Net income 4.47 M4.75 M4.31 M7.4 M 20.93 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 4.47 M4.75 M4.31 M7.4 M 20.93 M Basic earnings per share (Basic EPS) 0.310.330.30.52 1.46 Diluted earnings per share (Diluted EPS) 0.310.330.30.5 1.44 Average basic shares outstanding 14.26 M14.27 M14.28 M14.29 M 57.1 M Diluted shares outstanding 14.55 M14.55 M14.53 M14.48 M 58.11 M EBITDA 7.64 M6.65 M6.21 M11.36 M 31.87 M EBIT 7.74 M6.76 M6.34 M11.5 M 32.35 M Cost of revenue 721 K1.09 M2.22 M-182 K 3.85 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) -101 K-113 K-128 K-137 K -479 K